Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction

Tissue Engineering - Part A

Volumn 17, Issue 1-2, 2011, Pages 45-58

  Guo, Hai Dong ^a   Wang, Hai Jie ^a   Tan, Yu Zhen ^a   Wu, Jin Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BROMINE COMPOUNDS; CELL DEATH; CHROMOSOMES; FLUORESCENCE MICROSCOPY; POPULATION STATISTICS; STEM CELLS; TRANSCRIPTION FACTORS;

ANGIOGENESIS; APOPTOSIS; CARDIAC FUNCTIONS; CARDIAC TROPONIN; CARDIOMYOCYTES; CELL IMPLANTATION; CELL SURVIVAL; CONNEXIN-43; CYTOPROTECTIVE EFFECTS; DEATH RATES; FEMALE RAT; FIBRIN GLUE; FLUORESCENCE IN SITU HYBRIDIZATION; IN-VITRO; LACTATE DEHYDROGENASE; MATRIX; MICROENVIRONMENTS; MICROVESSEL DENSITY; MYOCARDIAL INFARCTION; RAT BONE MARROW; STEM CELL TRANSPLANTATION; Y CHROMOSOMES;

HEART;

RATTUS;

CONNEXIN 43; HOMEODOMAIN PROTEIN; MADS DOMAIN PROTEIN; MEF2C PROTEIN, HUMAN; MYOGENIC FACTOR; NKX2.5 PROTEIN, RAT; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; TROPONIN T;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CONNEXIN 43; FEMALE; GATA4 TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEINS; MADS DOMAIN PROTEINS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; RATS; STEM CELL TRANSPLANTATION; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; TROPONIN T;

EID: 78650912022     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0124     Document Type: Article

References (46)

1. Mann, D.L. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100, 999, 1999.
2. Crisostomo, P.R., Wang, M, Markel, T.A., Lahm, T, Abar-banell, A.M., Herrmann, J.L., and Meldrum, D.R. Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28, 375, 2007.
3. Gu, Y., Yu, J., Lum, L.G., and Lee, R.J. Tissue engineering and stem cell therapy for myocardial repair. Front Biosci 12, 5157, 2007.
4. Yin, A.H., Miraglia, S., Zanjani, ED., Almeida-Porada, G., Ogawa, M., Leary, A.G., Olweus, J., Kearney, J., and Buck, D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002, 1997.
5. Bhatia, M., Bonnet, D., Murdoch, B., Gan, O.I., and Dick, J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4, 1038, 1998.
6. Taylor, D.A., Atkins, B.Z., Hungspreugs, P., Jones, T.R., Reedy, M.C., Hutcheson, K.A., Glower, D.D., and Kraus, W.E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4, 929, 1998.
7. Scorsin, M., Hagège, A., Vilquin, J.T., Fiszman, M., Marotte, F., Samuel, J.L., Rappaport, L., Schwartz, K., and Menasché, P. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119, 1169, 2000.
8. Tang, Y.L. Cellular therapy with autologous skeletal myo-blasts for ischemic heart disease and heart failure. Methods Mol Med 112, 193, 2005.
9. Murry, C.E., Wiseman, R.W., Schwartz, S.M., and Hauschka, S.D. Skeletal myoblast transplantation for repair of myo-cardial necrosis. J Clin Invest 98, 2512, 1996.
10. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5, 485, 2003.
11. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A., and Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410, 6829, 2001.
12. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., and Anversa, P. Adult cardiac stem cells are multipotent and support myo-cardial regeneration. Cell 114, 763, 2003.
13. Gojo, S., Gojo, N., Takeda, Y., Mori, T., Abe, H., Kyo, S., Hata, J., and Umezawa, A. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288, 51, 2003.
14. Matsuura, K., Nagai, T., Nishigaki, N., Oyama, T., Nishi, J., Wada, H., Sano, M., Toko, H., Akazawa, H., Sato, T., Na-kaya, H., Kasanuki, H., and Komuro, I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279, 11384, 2004.
15. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M., Battaglia, M., Latronico, M.V., Coletta, M., Vivarelli, E., Frati, L., Cossu, G., and Giacomello, A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95, 911, 2004.
16. Sun, L.L., Tan, Y.Z., Wang, H.J., and He, Q.Z. Cloning culture of the marrow mesenchymal stem cells and their differentiation towards cardiomyocytes. Fudan Univ J Med Sci 30, 519, 2003.
17. Zhang, G.T., Tan, Y.Z., Wang, H.J., Ao, H., Guo, H.D., and Huang, G.Y. Effects of marrow-derived cardiac stem cell transplantation after myocardial infarction in rats. Zhong Hua Xin Xue Guan Bing Za Zhi 35, 940, 2007.
18. Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., and Murry, C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33, 907, 2001.
19. Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J., Majesky, M.W., Entman, M.L., Michael, L.H., Hirschi, K.K., and Goodell, M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107, 1395, 2001.
20. Murry, C.E., Whitney, M.L., Laflamme, M.A., Reinecke, H., and Field, L.J. Cellular therapies for myocardial infarct repair. Cold Spring Harb Symp Quant Biol 67, 519, 2002.
21. Azarnoush, K., Maurel, A., Sebbah, L., Carrion, C., Bissery, A., Mandet, C., Pouly, J., Bruneval, P., Hagège, A.A., and Menasché, P. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadminis-tration of hypoxia-inducible factor 1alpha. J Thorac Cardiovasc Surg 130, 173, 2005.
22. Aicher, A., Brenner, W., Zuhayra, M., Badorff, C., Massoudi, S., Assmus, B., Eckey, T., Henze, E., Zeiher, A.M., and Dimmeler, S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107, 2134, 2003.
23. Shake, J.G., Gruber, P.J., Baumgartner, W.A., Senechal, G., Meyers, J., Redmond, J.M., Pittenger, M.F., and Martin, B.J. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73, 1919, 2002.
24. Christman, K.L., and Lee, R.J. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48, 907, 2006.
25. Leo, A.J., and Grande, D.A. Mesenchymal stem cells in tissue engineering. Cells Tissues Organs 183, 112, 2006.
26. Ho, W., Tawil, B., Dunn, J.C., and Wu, B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12, 1587, 2006.
27. Zhang, G., Wang, X., Wang, Z., Zhang, J., and Suggs, L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng 12, 9, 2006.
28. Martens, T.P., Godier, A.F., Parks, J.J., Wan, L.Q., Koeckert, M.S., Eng, G.M., Hudson, B.I., Sherman, W., and Vunjak-Novakovic, G. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant 18, 297, 2009.
29. Christman, K.L., Fok, H.H., Sievers, R.E., Fang, Q., and Lee, R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 10, 403, 2004.
30. Ryu, J.H., Kim, I.K., Cho, S.W., Cho, M.C., Hwang, K.K., Piao, H., Piao, S., Lim, S.H., Hong, Y.S., Choi, C.Y., Yoo, K.J., and Kim, B.S. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 97, 194, 1989.
31. Zhang, G., Hu, Q., Braunlin, E.A., Suggs, L.J., and Zhang, J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng Part A 14, 1025, 2008.
32. Yoon, Y.S., Wecker, A., Heyd, L., Park, J.S., Tkebuchava, T., Kusano, K., Hanley, A., Scadova, H., Qin, G., Cha, D.H., Johnson, K.L., Aikawa, R., Asahara, T., and Losordo, D.W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myo-cardial infarction. Science 115, 326, 2005.
33. Hori, O., Matsumoto, M., Kuwabara, K., Maeda, Y., Ueda, H., Ohtsuki, T., Kinoshita, T., Ogawa, S., Stern, D.M., and Kamada, T. Exposure of astrocytes to hypoxia/ reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotec-tive cytokine interleukin 6. J Neurochem 66, 973, 1996.
34. Rousou, J., Levitsky, S., Gonzalez-Lavin, L., Cosgrove, D., Magilligan, D., Weldon, C., Hiebert, C., Hess, P., Joyce, L., Bergsland, J., et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 97, 194, 1989.
35. Taylor, S.J., McDonald, J.W., and Sakiyama-Elbert, S.E. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release 98, 281, 2004.
36. Nicosia, R.F., and Ottinetti, A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in Matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 26, 119, 1990.
37. Vailhe, B., Ronot, X., Tracqui, P., Usson, Y., and Tranqui, L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell Dev Biol Anim 33, 763, 1997.
38. Bach, T.L., Barsigian, C., Chalupowicz, D.G., Busler, D., Yaen, C.H., Grant, D.S., and Martinez, J. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res 238, 324, 1998.
39. Thompson, W.D., Smith, E.B., Stirk, C.M., Marshall, F.I., Stout, A.J., and Kocchar, A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol 168, 47, 1992.
40. Bootle-Wilbraham, C.A., Tazzyman, S., Thompson, W.D., Stirk, C.M., and Lewis, C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4, 269, 2001.
41. Naito, M., Stirk, C.M., Smith, E.B., and Thompson, W.D. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis. Thromb Res 98, 165, 2000.
42. Sierra, D.H. Fibrin sealant adhesive systems: A review of their chemistry, material properties and clinical applications. J Biomater Appl 7, 309, 1993.
43. Neuss, S., Schneider, R.K., Tietze, L., Knü chel, R., and Jah-nen-Dechent, W. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs 191, 36, 2010.
44. Bretland, A.J., Lawry, J., and Sharrard, R.M. A study of death by anoikis in cultured epithelial cells. Cell Prolif 34, 199, 2001.
45. Quevedo, H.C., Hatzistergos, K.E., Oskouei, B.N., Feigen-baum, G.S., Rodriguez, J.E., Valdes, D., Pattany, P.M., Zambrano, J.P., Hu, Q., McNiece, I., Heldman, A.W., and Hare, J.M. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trili-neage differentiating capacity. Proc Natl Acad Sci USA 106, 14022, 2009.
46. Li, Y.S., and Gao, B.R. Transplantation of neonatal cardiomyocytes plus fibrin sealant restores myocardial function in a rat model of myocardial infarction. Chin Med J (Engl) 120, 2022, 2007.